ROTHBLATT MARTINE A
SEC CIK 1106578 · EDGAR
BoughtSold
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $844.54M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 665
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-07 16:30 | 2026-05-06 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-05-07 16:30 | 2026-05-06 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $589.52 | -9,500 | 40.5K | -19% | -$5.60M |
| DT | 2026-05-06 17:04 | 2026-05-05 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-05-06 17:04 | 2026-05-05 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $576.24 | -9,500 | 40.5K | -19% | -$5.47M |
| DT | 2026-05-05 16:31 | 2026-05-04 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-05-05 16:31 | 2026-05-04 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $576.97 | -9,500 | 40.5K | -19% | -$5.48M |
| DT | 2026-05-04 16:54 | 2026-05-01 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-05-04 16:54 | 2026-05-01 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $570.58 | -9,500 | 40.5K | -19% | -$5.42M |
| DT | 2026-05-01 16:57 | 2026-04-30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-05-01 16:57 | 2026-04-30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $572.63 | -9,500 | 40.5K | -19% | -$5.44M |
| DT | 2026-04-30 16:30 | 2026-04-29 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-30 16:30 | 2026-04-29 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $571.22 | -9,500 | 40.5K | -19% | -$5.43M |
| DT | 2026-04-29 16:31 | 2026-04-28 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-29 16:31 | 2026-04-28 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $568.04 | -9,500 | 40.5K | -19% | -$5.40M |
| DT | 2026-04-28 18:04 | 2026-04-27 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-28 18:04 | 2026-04-27 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $568.81 | -9,500 | 40.5K | -19% | -$5.40M |
| DT | 2026-04-27 16:39 | 2026-04-24 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-27 16:39 | 2026-04-24 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $564.81 | -9,500 | 40.5K | -19% | -$5.37M |
| DT | 2026-04-24 16:32 | 2026-04-23 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-24 16:32 | 2026-04-23 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $572.35 | -9,500 | 40.5K | -19% | -$5.44M |
| DT | 2026-04-23 16:53 | 2026-04-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-23 16:53 | 2026-04-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $576.56 | -9,500 | 40.5K | -19% | -$5.48M |
| DMT | 2026-04-22 16:30 | 2026-04-21 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-22 16:30 | 2026-04-21 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $570.42 | -9,500 | 40.5K | -19% | -$5.42M |
| DT | 2026-04-21 07:41 | 2026-04-20 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-21 07:41 | 2026-04-20 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $577.83 | -9,500 | 40.5K | -19% | -$5.49M |
| DT | 2026-04-20 16:38 | 2026-04-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-20 16:38 | 2026-04-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $586.66 | -9,500 | 40.5K | -19% | -$5.57M |
| DT | 2026-04-17 16:57 | 2026-04-16 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-17 16:57 | 2026-04-16 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $577.21 | -9,500 | 40.5K | -19% | -$5.48M |
| DTI | 2026-04-16 16:31 | 2026-03-13 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $536.95 | -75 | 324.4K | -0.0% | -$40.3K |
| DMT | 2026-04-16 16:31 | 2026-04-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +19.0K | 50.0K | +61% | +$2.77M |
| DMT | 2026-04-16 16:31 | 2026-04-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $579.86 | -19.0K | 40.5K | -32% | -$11.02M |
| DT | 2026-04-14 16:34 | 2026-04-13 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-14 16:34 | 2026-04-13 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $574.86 | -9,500 | 40.5K | -19% | -$5.46M |
| DT | 2026-04-13 16:32 | 2026-04-10 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-13 16:32 | 2026-04-10 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $569.28 | -9,500 | 40.5K | -19% | -$5.41M |
| DT | 2026-04-10 16:32 | 2026-04-09 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-10 16:32 | 2026-04-09 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $577.88 | -9,500 | 40.5K | -19% | -$5.49M |
| DT | 2026-04-09 16:30 | 2026-04-08 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-09 16:30 | 2026-04-08 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $580.45 | -9,500 | 40.5K | -19% | -$5.51M |
| DT | 2026-04-08 16:33 | 2026-04-07 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-08 16:33 | 2026-04-07 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $564.01 | -9,500 | 40.5K | -19% | -$5.36M |
| DT | 2026-04-07 16:35 | 2026-04-06 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-07 16:35 | 2026-04-06 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $558.41 | -9,500 | 40.5K | -19% | -$5.30M |
| DT | 2026-04-06 16:42 | 2026-04-02 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-06 16:42 | 2026-04-02 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $561.37 | -9,500 | 40.5K | -19% | -$5.33M |
| DT | 2026-04-02 16:35 | 2026-04-01 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-02 16:35 | 2026-04-01 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $581.63 | -9,500 | 40.5K | -19% | -$5.53M |
| DT | 2026-04-02 16:34 | 2026-03-31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-04-02 16:34 | 2026-03-31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $585.76 | -9,500 | 40.5K | -19% | -$5.56M |
| DT | 2026-03-31 | 2026-03-30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-03-31 | 2026-03-30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $590.58 | -9,500 | 40.5K | -19% | -$5.61M |
| DMT | 2026-03-31 | 2026-03-27 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $526.96 | -9,500 | 42.5K | -18% | -$5.01M |
| DT | 2026-03-31 | 2026-03-27 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-03-27 | 2026-03-26 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $535.81 | -9,500 | 46.2K | -17% | -$5.09M |
| DT | 2026-03-27 | 2026-03-26 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DT | 2026-03-26 | 2026-03-25 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-03-26 | 2026-03-25 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $543.73 | -9,500 | 45.9K | -17% | -$5.17M |
| DT | 2026-03-25 | 2026-03-24 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-03-25 | 2026-03-24 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $529.36 | -9,500 | 50.0K | -16% | -$5.03M |
| DMT | 2026-03-24 | 2026-03-23 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $527.01 | -9,500 | 45.5K | -17% | -$5.01M |
| DT | 2026-03-24 | 2026-03-23 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-03-23 | 2026-03-20 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $524.99 | -9,500 | 42.7K | -18% | -$4.99M |
| DT | 2026-03-23 | 2026-03-20 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-03-20 | 2026-03-19 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $528.83 | -9,500 | 49.4K | -16% | -$5.02M |
| DT | 2026-03-20 | 2026-03-19 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-03-19 | 2026-03-18 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $529.59 | -9,500 | 50.0K | -16% | -$5.03M |
| DT | 2026-03-19 | 2026-03-18 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-03-18 | 2026-03-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $536.75 | -9,500 | 45.2K | -17% | -$5.10M |
| DT | 2026-03-18 | 2026-03-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DMT | 2026-03-17 | 2026-03-16 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $533.90 | -9,500 | 44.8K | -18% | -$5.07M |
| DT | 2026-03-17 | 2026-03-16 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 50.0K | +23% | +$1.39M |
| DM | 2026-03-17 | 2026-03-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | F - Tax | $536.12 | -29.2K | 56.1K | -34% | -$15.65M |
| DM | 2026-03-17 | 2026-03-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | — | +69.6K | 69.7K | +53,522% | — |
| DMT | 2026-03-16 | 2026-03-12+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $537.81 | -9,500 | 3,610 | -72% | -$5.11M |
| DT | 2026-03-16 | 2026-03-12 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 9,630 | +7,308% | +$1.39M |
| DT | 2026-03-16 | 2026-03-13 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 9,630 | +7,308% | +$1.39M |
| DMT | 2026-03-16 | 2026-03-13 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $538.00 | -9,500 | 210 | -98% | -$5.11M |
| DT | 2026-03-11 | 2026-03-11 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 9,630 | +7,308% | +$1.39M |
| DMT | 2026-03-11 | 2026-03-11 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $539.54 | -9,500 | 4,790 | -66% | -$5.13M |
| DMT | 2026-03-11 | 2026-03-10 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $539.71 | -9,500 | 8,830 | -52% | -$5.13M |
| DT | 2026-03-11 | 2026-03-10 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 9,630 | +7,308% | +$1.39M |
| DMT | 2026-03-10 | 2026-03-06 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $477.67 | -9,500 | 6,986 | -58% | -$4.54M |
| DT | 2026-03-10 | 2026-03-06 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 9,630 | +7,308% | +$1.39M |
| DMT | 2026-03-10 | 2026-03-09 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $518.03 | -9,500 | 4,160 | -70% | -$4.92M |
| DT | 2026-03-10 | 2026-03-09 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 9,630 | +7,308% | +$1.39M |
| DMT | 2026-03-09 | 2026-03-05 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $484.55 | -9,500 | 8,870 | -52% | -$4.60M |
| DT | 2026-03-09 | 2026-03-05 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 9,630 | +7,308% | +$1.39M |
| DMT | 2026-03-05 | 2026-03-03 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $499.42 | -9,500 | 551 | -95% | -$4.74M |
| DT | 2026-03-05 | 2026-03-03 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 9,630 | +7,308% | +$1.39M |
| DMT | 2026-03-05 | 2026-03-04 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale | $317.97 | 0 | 650 | New | $0 |
| DMT | 2026-03-03 | 2026-03-02 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $515.37 | -9,500 | 330 | -97% | -$4.90M |
| DT | 2026-03-03 | 2026-03-02 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $146.03 | +9,500 | 9,630 | +7,308% | +$1.39M |
| 2026-02-03 | 2026-01-30 | BETA | BETA Technologies, Inc. | ROTHBLATT MARTINE A | Dir | A - Grant | $0.00 | +1,071 | 1,071 | New | $0 | |
| DMT | 2025-12-19 | 2025-12-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +10.0K | 4,130 | New | +$1.20M |
| DMT | 2025-12-19 | 2025-12-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $505.38 | -10.0K | 130 | -99% | -$5.05M |
| DMT | 2025-12-16 | 2025-12-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $494.09 | -8,000 | 1,630 | -83% | -$3.95M |
| DMT | 2025-12-16 | 2025-12-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-12-12 | 2025-12-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $487.33 | -8,000 | 130 | -98% | -$3.90M |
Purchase Sale Sale after option exercise All abbreviations